XML 66 R51.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of domestic and foreign components of loss before income taxes
The following table presents domestic and foreign components of loss before income taxes for the periods presented:
Year Ended December 31,
202320222021
(In thousands)
United States$(816,089)$(1,021,208)$(737,360)
International(180,640)(222,424)(223,569)
Loss before (provision for) benefit from income taxes
$(996,729)$(1,243,632)$(960,929)
Schedule of provision for (benefit from) income taxes
Provision for (benefit from) income taxes consists of the following:
Year Ended December 31,
202320222021
Current:(In thousands)
Federal$2,567 $3,928 $122 
State1,533 4,100 420 
Foreign31,354 17,450 8,274 
Total35,454 25,478 8,816 
Deferred:
Federal(1,337)(5,155)(13,772)
State(208)(818)(4,083)
Foreign(15,197)(6,992)(1,990)
Total(16,742)(12,965)(19,845)
Provision for (benefit from) income taxes$18,712 $12,513 $(11,029)
Schedule of reconciliation of statutory federal tax rate and effective tax rate
The following table presents a reconciliation of the statutory federal tax rate and the Company's effective tax rate:
Year Ended December 31,
202320222021
Tax at federal statutory rate21 %21 %21 %
State tax, net of federal benefit
Stock-based compensation(7)(7)16 
Credits
Foreign rate differential(2)(1)
Change in valuation allowance(23)(17)(46)
Other(1)— 
Effective tax rate(2)%(2)%%
Schedule of deferred tax assets and liabilities The following table presents the significant components of the Company's deferred tax assets and liabilities:
As of December 31,
20232022
Deferred tax assets:(In thousands)
Net operating loss carryforwards$983,652 $959,864 
Accruals and reserves52,750 47,986 
Stock-based compensation29,572 37,981 
Research and development credits177,109 159,604 
Intangibles135,564 135,500 
Capitalized research and development expenses231,819 219,176 
Lease liability44,682 60,795 
Unrealized losses on marketable securities— 32,108 
Investments and other basis differences51,368 11,952 
Other31,852 24,878 
Gross deferred tax assets1,738,368 1,689,844 
Valuation allowance(1,533,933)(1,357,300)
Net deferred tax assets204,435 332,544 
Deferred tax liabilities:
Capitalized software(36,109)(36,552)
Prepaid expenses(1,073)(1,587)
Acquired intangibles(81,415)(202,778)
Right-of-use asset(19,964)(35,734)
Deferred commissions(50,703)(59,675)
Net deferred tax asset (liability)
$15,171 $(3,782)
Schedule of operating loss carryforwards
The following table summarizes the Company’s tax carryforwards, carryovers and credits:
As of
December 31, 2023
Expiration Date
(If not utilized)
(In thousands)
Federal tax credits$147,500 Various dates beginning in 2037
Federal net operating loss carryforwards$3,444,800 Indefinite
State net operating loss carryforwards$2,640,300 Various dates beginning in 2026
State tax credits$120,300 Indefinite
Foreign net operating loss carryforwards$1,011,800 Indefinite
Schedule of tax credit carryforwards
The following table summarizes the Company’s tax carryforwards, carryovers and credits:
As of
December 31, 2023
Expiration Date
(If not utilized)
(In thousands)
Federal tax credits$147,500 Various dates beginning in 2037
Federal net operating loss carryforwards$3,444,800 Indefinite
State net operating loss carryforwards$2,640,300 Various dates beginning in 2026
State tax credits$120,300 Indefinite
Foreign net operating loss carryforwards$1,011,800 Indefinite
Schedule of unrecognized tax benefits
A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
Year Ended December 31,
202320222021
(In thousands)
Unrecognized tax benefit, beginning of year$228,966 $223,380 $191,183 
Gross increases for tax positions of prior years3,427 3,250 3,496 
Gross decreases for tax positions of prior years(5,130)(705)(10,693)
Gross increases for tax positions of current year7,754 4,081 39,394 
Lapse of statute of limitations(1,239)(1,040)— 
Unrecognized tax benefit, end of year$233,778 $228,966 $223,380